Selectis Health (GBCS) appoints veteran banker Richard Huebner to board

Rhea-AI Filing Summary

Selectis Health, Inc. reported that its Board of Directors approved the appointment of Richard Huebner, age 68, as a new director effective March 12, 2026. Huebner has served as senior managing partner and investment banker at GVC Capital LLC since 2001 and previously held senior roles at Fiserv Correspondent Services and Hanifen Imhoff entities, as well as legal and compliance positions at First Mid America, Inc.

He holds a bachelor’s degree from Hastings College in Nebraska (1979) and a Juris Doctor degree from the University of Nebraska (1982). As an outside director, Huebner will be eligible to participate in the company’s Outside Directors Compensation Plan and receive an annual cash stipend of $30,000, payable quarterly.

false 0000727346 0000727346 2026-03-12 2026-03-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 12, 2026

SELECTIS HEALTH, INC.

(Exact Name of Registrant as Specified in its Charter)

Utah		0-15415		87-0340206
(State or other jurisdiction of incorporation)		Commission File Number		(I.R.S. Employer Identification number)

600 17th St., Ste 2800 South, Denver, CO 80202

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (720) 680-0808

(Former name or former address, if changed since last report)

☐	Written communications pursuant to Rule 425 under the Securities Act
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class		Trading Symbol		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 5.02 APPOINTMENT OF DIRECTORS

Effective March 12, 2026, the Board of Directors of Selectis Health, Inc, a Utah corporation (the “Company”) approved the appointment of Mr. Richard Huebner to serve as a member of the Board of Directors of Company.

The following is biographical information on the new Board member:

Richard Huebner, age 68 has served as the senior managing partner and investment banker of GVC Capital LLC since 2001 to the present. Prior to this Mr. Huebner was a registered investment advisor from 2000 to 2001. He was also an Executive Vice President at Fiserv Correspondent Services from 1984 to 2000. Mr. Huebner served in various roles including General Counsel, Director, Executive Committee Member, Compliance Officer, Equities Desk Trader, Vice President, Senior and Executive Vice Present at Hanifen Imhoff Inc, (1979) Hanifen Imhoff Holding Company, Hanifen Imhoff Investments, Hanifen Imhoff Clearing Corp from 1984 through 1997. From 1980 through 1983 he held the positions of Law Clerk, Compliance Officer and Assistant General Counsel and First Mid America, Inc.

Mr. Huebner received a Bachelor’s degree from Hastings College in Nebraska (1979) and a Juris Doctorate degree from University of Nebraska (1982).

Mr. Huebner will be eligible to participate in the Company’s previously approved Outside Directors Compensation Plan under which he will receive an annual stipend of $30,000, payable quarterly in cash.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Selectis Health, Inc.
	(Registrant)
Dated: March 18, 2026	/s/ Adam Desmond
	Adam Desmond CEO

FAQ

What board change did Selectis Health (GBCS) disclose?

Selectis Health added Richard Huebner to its Board of Directors effective March 12, 2026. He joins as an outside director with extensive investment banking, legal, and compliance experience across GVC Capital, Fiserv Correspondent Services, Hanifen Imhoff entities, and First Mid America, Inc.

Who is Richard Huebner, the new Selectis Health (GBCS) director?

Richard Huebner is 68 and has been senior managing partner and investment banker at GVC Capital LLC since 2001. His background includes executive roles at Fiserv Correspondent Services and Hanifen Imhoff entities, plus legal and compliance positions at First Mid America, Inc.

What compensation will Richard Huebner receive as a Selectis Health (GBCS) director?

As an outside director, Richard Huebner will receive an annual cash stipend of $30,000. The amount is payable quarterly under Selectis Health’s existing Outside Directors Compensation Plan approved for non-employee board members.

When did Richard Huebner’s appointment to the Selectis Health (GBCS) board become effective?

Richard Huebner’s appointment to the Selectis Health Board of Directors became effective on March 12, 2026. The Board formally approved his appointment on that date, and the company later documented the change in its current report.

What is Richard Huebner’s educational background relevant to his Selectis Health (GBCS) role?

Richard Huebner holds a bachelor’s degree from Hastings College in Nebraska, earned in 1979. He also received a Juris Doctor degree from the University of Nebraska in 1982, supporting his long career in legal, compliance, and investment banking roles.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB